EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High-Dose Neutrophil-Depleted Platelet-Rich Plasma Therapy for Knee Osteoarthritis: A Retrospective Study

Andrea De Matthaeis, Maria Bianchi iD, Rossana Putzulu, Giulio Maccauro

Journal of Clinical Medicine · 15.08.2024 · 13 (16) · 4816

DOI: 10.3390/jcm13164816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.08.2024. Verfasst von Andrea De Matthaeis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Traumatology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 …. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Encouraging results have been reported for Platelet-Rich Plasma (PRP) treatment for knee osteoarthritis (KOA). This study reports the efficacy and safety of a high dose of neutrophile and red-blood-cell-depleted PRP to treat patients with KOA.

Methods

A total of 212 consecutive patients diagnosed with Kellgren–Lawrence (KL) grading 1–3 KOA chronic knee pain for at least 1 year were treated with three injections at 15-day intervals with a high dose of neutrophil-depleted PRP (4 billion platelets). Clinical outcomes were retrospectively recorded as the percentage of responders at 3-, 6-, and 12-month follow-up, following the OMERACT-OARSI criteria. Pain, through the VAS score and WOMAC score, was also been recorded.

Results

A total of 4 mL of PRP containing 4 × 109 platelets was obtained by single-spin centrifugation and injected intra-articularly into each patient with no preactivation. The overall responder rate of patients responding to the OMERACT-OARSI criteria at 3, 6, and 12 months was 68.9%, 72.7%, and 70.6%, respectively. A significant improvement in VAS and WOMAC scores at 3-, 6-, and 12-month follow-up compared to the pretreatment value (p < 0.01) was observed. The lowest VAS score was observed at 6 months overall and in all three KL-graded groups. The KL2 groups showed the best results regarding pain reduction and their WOMAC score at 6 months (p < 0.01).

Conclusions

For KL1–3 KOA, a high dosage of neutrophil-depleted PRP is a successful treatment. It has long-lasting effects that last up to one year, relieves symptoms, and may slow the advancement of the disease.

Schlagwörter

Stichwörter der Autor:innen

cartilage regenerationknee osteoarthritisplatelet-rich plasmaregenerative medicine

Autor:innen und Institutionen

  • Department of Orthopedics and Traumatology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, 00168 Rome, Italy.

ORCID-Profile: Maria Bianchi

Zitieren

APA

De Matthaeis, A., Bianchi, M., Putzulu, R., & Maccauro, G. (2024). High-Dose Neutrophil-Depleted Platelet-Rich Plasma Therapy for Knee Osteoarthritis: A Retrospective Study. Journal of Clinical Medicine, 13(16), 4816. https://doi.org/10.3390/jcm13164816

Vancouver

De Matthaeis A, Bianchi M, Putzulu R, Maccauro G. High-Dose Neutrophil-Depleted Platelet-Rich Plasma Therapy for Knee Osteoarthritis: A Retrospective Study. Journal of Clinical Medicine. 2024;13(16):4816. doi:10.3390/jcm13164816

BibTeX
@article{DeMatthaeis2024,
  author = {De Matthaeis, Andrea and Bianchi, Maria and Putzulu, Rossana and Maccauro, Giulio},
  title = {High-Dose Neutrophil-Depleted Platelet-Rich Plasma Therapy for Knee Osteoarthritis: A Retrospective Study},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {16},
  pages = {4816},
  doi = {10.3390/jcm13164816}
}
Kostenlos starten →